HomeGenie
Patented home testing platform using computer vision and machine learning to verify identity, sampling compliance and test results.
HomeGenie (Docnostics) is an AI-powered home testing and sample collection platform combining a patented physical capture kit with computer-vision identity verification and procedural compliance monitoring — enabling trusted, certifiable at-home diagnostics across COVID-19, genomics, drug screening and infectious disease clearance.
Source documents, patent diagrams, deck pages, product renders and press coverage — the primary visual evidence behind this programme. Click any artefact to enlarge.
The same architecture re-drawn in the MedeAIR design system — animated, interactive, and built directly from the original patent and deck artefacts above.
A patented capture kit + AI vision = trusted at-home diagnostics.
Identity verified
Computer-vision verification of the user via phone-front camera before the kit can be opened.
Sampling monitored
AI vision observes vial holder + outer sleeve alignment; procedural compliance scored in real time.
Result certified
Negative results generate verifiable digital certificates for travel or venue access.
Auto-reported
Positive results forwarded automatically to the relevant monitoring body via API.
- 2020
Concept
Clinician-designed response to Covid-19 testing scale limits — verifiable at-home sampling with computer-vision compliance.
- 2020
Patent secured
Full patent granted on the HomeGenie capture kit (vial holder, vial housing, outer sleeve, instruction card).
- 2021
Pre-production prototype
Working pre-production prototype manufactured. AI computer vision product scoped with delivery partners.
- 2021
Clinical trials secured
Two ethics-approved clinical trials at St James's University Hospital and Beaumont University Hospital for remote DNA sample capture with RCSI Genomics.
- 2022
Customer validation
Interviews with Boots (CIO), UniPharm community pharmacies and antigen test providers to validate retail-channel market fit.
COVID-19 exposed the limitations of scaling public testing and sampling capacity. HomeGenie was conceived by clinicians to dissolve the bottleneck: a low-cost kit, paired with a phone-based AI vision system, that verifies the user's identity, observes sample collection technique end-to-end, and certifies the result.
Negative results generate verifiable certificates for travel or venue access; positive results are reported automatically to the relevant monitoring body. The same capture process unlocks downstream use cases including remote genomic sampling, virtual clinical trials, workplace compliance testing, infectious disease clearance and accessible testing for visually impaired patients.
HomeGenie operates a B2B2C model with antigen and PCR providers, distributed through online and high-street pharmacies. The platform addresses a COVID-19 diagnostics market projected at USD 11.4 billion (2020–2027, 7.9% CAGR) and the broader global drug screening market estimated at USD 4.8 billion growing at 15.8% CAGR.
- Patented home testing capture kit
- Computer-vision identity verification
- Procedural compliance monitoring
- Automated result certification
- Regulatory reporting integration
- Multi-modality sampling (antigen, PCR, genomics, drug screening)
Full patent secured on the HomeGenie capture kit. AI Computer Vision product scoped with delivery partners.
Two ethics-approved clinical trials secured at Ireland's largest university hospitals — St James's University Hospital and Beaumont University Hospital — for remote DNA sample capture in partnership with the RCSI Department of Genomics.
CeADAR — Ireland's Centre for Applied AI; RCSI Department of Genomics; charity partnerships (including Fighting Blindness) for visually impaired remote testing of pregnancy, COVID and other diagnostics.
Customer validation interviews with Boots (CIO), UniPharm community pharmacies and pharmaceutical antigen test providers for retail-level remote testing.
- HomeGenie capture kit — granted
- St James's University Hospital
- Beaumont University Hospital
- Royal College of Surgeons in Ireland (RCSI) — Genomics
- CeADAR — Ireland's Centre for Applied AI
- Fighting Blindness
- Boots
- UniPharm
Royal Flying Doctor Service
National strategic review reframing aeromedical retrieval as a virtual critical care network — a decade before virtual care became standard.
Quantum Consult™
Patented multimodal pre-consultation engine — adaptive video, audio and text intake that matches patients to specialists and clinical trials.
Akkure Genomics
Patient-owned medical digital twins on blockchain — the world's first AI-powered, patient-controlled precision medicine and virtual trials ecosystem.